South and Central America Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country
Market Introduction
Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.
Get more information on this report :
Market Overview and Dynamics
TheSouth & Central Americakidney disease market is expected to reach US$ 9,060.9 million in 2027 from US$ 5,758.9million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as higher prevalence of kidney diseases in South & Central America and rising incidence rates of hypertension. However, the market is expected experiencing slow growth during the forecast period owing to an inadequate workforce to fight the burden of kidney diseases.
Key Market Segments
Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.
Major Sources and Companies Listed
Some of the major primary and secondary sources forkidney disease market included in the report areBrazilian Society of Nephrology, Latin American Dialysis and Transplant Registry, and others.
Reasons to buy the report
- To understand the South & Central Americakidney disease market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for kidney disease market
- Efficiently plan M&A and partnership deals in South & Central Americakidney disease market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment formKidney disease market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in South & Central America region
SOUTH & CENTRAL AMERICAKIDNEY DISEASE MARKET SEGMENTATION
· Diagnosis
o Blood Tests
o Urine Tests
o Imaging Tests
o Others
· Treatment
o Dialysis
o Others
o Drug Class
§ ACE Inhibitors
§ Angiotensin-II Receptor Blockers
§ Diuretics
§ Others
· Hospitals
· Diagnostic Laboratories
· Others
By Country
· South & Central America
o Brazil
o Argentina
Company Profiles
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVie Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Sysmex Corporation
- Siemens AG
- Amgen Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Kidney Disease Market – By Product
1.3.2 Kidney Disease Market – By End User
1.3.3 South & Central America Kidney Disease – By Country
2. South & Central America Kidney Disease – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central AmericaKidney Disease – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Kidney Disease Market- South & Central America PEST Analysis
4.3 Expert Opinion
5. South & Central AmericaKidney Disease - Key Market Dynamics
5.1 Market Drivers
5.1.1 Higher prevalence of Kidney Diseases in South & Central America
5.1.2 Rising Incidence Rates of Hypertension
5.2 Market Restraints
5.2.1 Inadequate Workforce to Fight the Burden of Kidney Diseases
5.3 Market Opportunities
5.3.1 Increased Contribution by the Governments of the Countries
5.4 Future Trends
5.4.1 Increased Number of Product Launches and Company Collaborations
5.5 Impact Analysis
6. Kidney Disease Market – South & Central America Analysis
6.1 South & Central AmericaKidney Disease Revenue Forecasts and Analysis
7. South & Central AmericaKidney Disease Analysis and Forecasts To 2027 – ByProduct
7.1 Overview
7.2 Kidney Disease Market Revenue Share, by Product (2019 and 2027)
7.3 Diagnosis
7.3.1 Overview
7.3.2 Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.3.3 Blood Tests
7.3.3.1 Overview
7.3.3.2 Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)
7.3.4 Urine Tests
7.3.4.1 Overview
7.3.4.2 Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.3.5 Imaging Tests
7.3.5.1 Overview
7.3.5.2 Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Treatment
7.4.1 Overview
7.4.2 Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3 Drug Class
7.4.3.1 Overview
7.4.3.2 Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.1 ACE Inhibitors
7.4.3.2.1.1 Overview
7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.2 Angiotensin-II Receptor Blockers
7.4.3.2.2.1 Overview
7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.3 Diuretics
7.4.3.2.3.1 Overview
7.4.3.2.3.2 Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.4 Others
7.4.3.2.4.1 Overview
7.4.3.2.4.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.4 Dialysis
7.4.4.1 Overview
7.4.4.2 Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8. South & Central AmericaKidney Disease Analysis – By End-User
8.1 Overview
8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
9. Kidney Disease Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 South and Central America: Kidney Disease Market
9.1.1 Overview
9.1.2 South and Central America: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 South and Central America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 South and Central America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 South and Central America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.3.2.1 South and Central America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
9.1.4 South and Central America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.5 South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.1.6 Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Brazil: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 Brazil: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 Brazil: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2.1 Brazil: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 Brazil: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.7 Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Argentina: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 Argentina: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Argentina: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2.1 Argentina: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Argentina: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic on South & Central AmericaKidney Disease
10.1 South & Central America: Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Teva Pharmaceutical Industries Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GlaxoSmithKline plc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
Source: Press Release, Newsletters, and Company Annual Report
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of terms
LIST OF TABLES
Table 1. South and Central America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. South and Central America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 3. South and Central America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 4. South and Central America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 5. South and Central America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 7. Brazil: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 8. Brazil: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 9. Brazil: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. Brazil: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Argentina: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. Argentina: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 13. Argentina: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 14. Argentina: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. Argentina: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms,Kidney disease
LIST OF FIGURES
Figure 1. Kidney Disease Segmentation
Figure 2. South & Central AmericaKidney Disease Overview
Figure 3. Diagnosis Segment Held Largest Share of Product inKidney Disease Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Kidney Disease Market - South & Central America PEST Analysis
Figure 6. Kidney Disease Market Impact Analysis of Driver and Restraints
Figure 7. South & Central AmericaKidney Disease – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Kidney Disease Market Revenue Share, by Product (2019 and 2027)
Figure 9. Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Kidney Disease Market Revenue Share, by End User (2019 and 2027)
Figure 23. Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. South and Central America: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. South and Central America Kidney Disease Market Revenue and Forecast to 2027 (USD Million)
Figure 28. South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)
Figure 29. Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic in South & Central Americaon Country Markets
The List of Companies - South and Central America Kidney Disease Market
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVie Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Sysmex Corporation
- Siemens AG
- Amgen Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central Americakidney disease market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in theSouth & Central America kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.